Metagenomic and metabolomic analysis of the toxic effects of trichloroacetamide-induced gut microbiome and urine metabolome perturbations in mice.

Disinfection byproducts (DBPs) in drinking water have been linked to various diseases, including colon, colorectal, rectal, and bladder cancer. Trichloroacetamide (TCAcAm) is an emerging nitrogenous DBP, and our previous study found that TCAcAm could induce some changes associated with host-gut microbiota co-metabolism. In this study, we used an integrated approach combining metagenomics, based on high-throughput sequencing, and metabolomics, based on nuclear magnetic resonance (NMR), to evaluate the toxic effects of TCAcAm exposure on the gut microbiome and urine metabolome. High-throughput sequencing revealed that the gut microbiome's composition and function were significantly altered after TCAcAm exposure for 90 days in Mus musculus mice. In addition, metabolomic analysis showed that a number of gut microbiota-related metabolites were dramatically perturbed in the urine of the mice. These results may provide novel insight into evaluating the health risk of environmental pollutants as well as revealing the potential mechanism of TCAcAm's toxic effects.

[1]  Yu Miao,et al.  Metagenomic Profiling of Antibiotic Resistance Genes and Mobile Genetic Elements in a Tannery Wastewater Treatment Plant , 2013, PloS one.

[2]  Yehao Liu,et al.  Exposing to Cadmium Stress Cause Profound Toxic Effect on Microbiota of the Mice Intestinal Tract , 2014, PloS one.

[3]  Ruth Ley,et al.  Unravelling the effects of the environment and host genotype on the gut microbiome , 2011, Nature Reviews Microbiology.

[4]  C. Pagliuca,et al.  Polyphenol metabolites from colonic microbiota exert anti-inflammatory activity on different inflammation models. , 2009, Molecular nutrition & food research.

[5]  E. Gerner,et al.  Polyamines and cancer: old molecules, new understanding , 2004, Nature Reviews Cancer.

[6]  F. Bäckhed,et al.  The gut microbiota — masters of host development and physiology , 2013, Nature Reviews Microbiology.

[7]  T. Klaenhammer,et al.  Invited review: Application of omics tools to understanding probiotic functionality. , 2011, Journal of dairy science.

[8]  Haifeng Lu,et al.  Symbiotic gut microbes modulate human metabolic phenotypes , 2008, Proceedings of the National Academy of Sciences.

[9]  C. Huttenhower,et al.  Metagenomic microbial community profiling using unique clade-specific marker genes , 2012, Nature Methods.

[10]  Steven R. Tannenbaum,et al.  Arsenic Exposure Perturbs the Gut Microbiome and Its Metabolic Profile in Mice: An Integrated Metagenomics and Metabolomics Analysis , 2014, Environmental health perspectives.

[11]  M Dosemeci,et al.  Drinking Water Source and Chlorination Byproducts I. Risk of Bladder Cancer , 1998, Epidemiology.

[12]  V. Tremaroli,et al.  Functional interactions between the gut microbiota and host metabolism , 2012, Nature.

[13]  S. Lee,et al.  Metabolic engineering of Escherichia coli for the production of cadaverine: A five carbon diamine , 2011, Biotechnology and bioengineering.

[14]  D. Brenner,et al.  Interactions between the intestinal microbiome and liver diseases. , 2014, Gastroenterology.

[15]  Brian J. Bennett,et al.  Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease , 2011, Nature.

[16]  B. Pearson,et al.  Alternative Spermidine Biosynthetic Route Is Critical for Growth of Campylobacter jejuni and Is the Dominant Polyamine Pathway in Human Gut Microbiota* , 2011, The Journal of Biological Chemistry.

[17]  M. Fischbach,et al.  A metabolomic view of how the human gut microbiota impacts the host metabolome using humanized and gnotobiotic mice , 2013, The ISME Journal.

[18]  J. Nicholson,et al.  Host-Gut Microbiota Metabolic Interactions , 2012, Science.

[19]  D. Wolf,et al.  Changes in cecal microbial metabolism of rats induced by individual and a mixture of drinking water disinfection by-products. , 2004, Cancer letters.

[20]  J. Nicholson,et al.  Therapeutic Modulation of Microbiota-Host Metabolic Interactions , 2012, Science Translational Medicine.

[21]  A. Swank,et al.  The disinfection by-products dichloro-, dibromo-, and bromochloroacetic acid impact intestinal microflora and metabolism in Fischer 344 rats upon exposure in drinking water. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[22]  E. Rampersaud,et al.  Exercise Attenuates PCB-Induced Changes in the Mouse Gut Microbiome , 2013, Environmental health perspectives.

[23]  Samuel I. Miller,et al.  The Microbiome and Inflammatory Bowel Disease: Is There a Therapeutic Role for Fecal Microbiota Transplantation? , 2012, The American Journal of Gastroenterology.

[24]  R Balfour Sartor,et al.  Microbial influences in inflammatory bowel diseases. , 2008, Gastroenterology.

[25]  A. Masclee,et al.  Understanding the role of tryptophan and serotonin metabolism in gastrointestinal function , 2009, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[26]  M. Kogevinas,et al.  Disinfection Byproducts and Bladder Cancer: A Pooled Analysis , 2004, Epidemiology.

[27]  Xian-Zhong Yan,et al.  NMR-based metabonomic investigations into the metabolic profile of the senescence-accelerated mouse. , 2008, Journal of proteome research.

[28]  G. Nardone,et al.  Gut--liver axis: the impact of gut microbiota on non alcoholic fatty liver disease. , 2012, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[29]  Hongqiang Ren,et al.  Identifying health effects of exposure to trichloroacetamide using transcriptomics and metabonomics in mice ( Mus musculus ). , 2013, Environmental science & technology.

[30]  S. Richardson,et al.  Halonitromethane drinking water disinfection byproducts: chemical characterization and mammalian cell cytotoxicity and genotoxicity. , 2004, Environmental science & technology.

[31]  M Dosemeci,et al.  Drinking Water Source and Chlorination Byproducts II. Risk of Colon and Rectal Cancers , 1998, Epidemiology.

[32]  L. Ferguson,et al.  Metabolomic analysis identifies inflammatory and noninflammatory metabolic effects of genetic modification in a mouse model of Crohn's disease. , 2010, Journal of proteome research.

[33]  E. Want,et al.  Systemic gut microbial modulation of bile acid metabolism in host tissue compartments , 2010, Proceedings of the National Academy of Sciences.

[34]  S. Richardson,et al.  Occurrence, synthesis, and mammalian cell cytotoxicity and genotoxicity of haloacetamides: an emerging class of nitrogenous drinking water disinfection byproducts. , 2008, Environmental science & technology.

[35]  Raul Rabadan,et al.  Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. , 2012, Cancer cell.

[36]  M. Antonelli,et al.  By-products in surface and reclaimed water disinfected with various agents , 2005 .

[37]  B. Roe,et al.  A core gut microbiome in obese and lean twins , 2008, Nature.

[38]  Hideyuki Suzuki,et al.  Upregulation of colonic luminal polyamines produced by intestinal microbiota delays senescence in mice , 2014, Scientific Reports.

[39]  Richard A. Flavell,et al.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity , 2012, Nature.

[40]  A. M. Lima,et al.  Cholinergic Signaling Exerts Protective Effects in Models of Sympathetic Hyperactivity-Induced Cardiac Dysfunction , 2014, PloS one.

[41]  E. K. Kemsley,et al.  Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. , 2011, Journal of proteome research.

[42]  R. Ley,et al.  Metabolic Syndrome and Altered Gut Microbiota in Mice Lacking Toll-Like Receptor 5 , 2010, Science.

[43]  H. Matsushime,et al.  TRPA1 regulates gastrointestinal motility through serotonin release from enterochromaffin cells , 2009, Proceedings of the National Academy of Sciences.

[44]  J. Nicholson,et al.  Gut microbiota composition and activity in relation to host metabolic phenotype and disease risk. , 2012, Cell metabolism.

[45]  H. Flint.  Obesity and the Gut Microbiota , 2011, Journal of clinical gastroenterology.

[46]  Markus Moll,et al.  IVIg Immune Reconstitution Treatment Alleviates the State of Persistent Immune Activation and Suppressed CD4 T Cell Counts in CVID , 2013, PloS one.

[47]  D. Tomé,et al.  Intestinal luminal nitrogen metabolism: role of the gut microbiota and consequences for the host. , 2013, Pharmacological research.

[48]  A. Gewirtz,et al.  Obesity and its associated disease: a role for microbiota? , 2012, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[49]  E. Balskus,et al.  Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme , 2012, Proceedings of the National Academy of Sciences.

[50]  J. Hampe,et al.  Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease , 2004, Gut.